蜜芽传媒

An immunotherapy drug has given new hope to patients with head and neck cancer, which is hard to treat. In a trial, 36% of those who took the drug - Nivolumab - were alive after a year, compared to 17% given chemotherapy. Dr Emma Smith from Cancer Research UK explains how immunotherapy works.

(Image: Kidney cancer cells. Credit: Science Photo Library)